DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

LinksSchließen

Referenz

Mann JF, Schmieder RE, McQueen M. et al.
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial.

Lancet 2008;
372: 547-553 doi:10.1016/S0140-6736(08)61236-2

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: